Structural and functional analyses of bacterial lipopolysaccharides

Microbes and Infection

Volumn 4, Issue 9, 2002, Pages 915-926

  Caroff, Martine ^a   Karibian, Doris ^a   Cavaillon, Jean Marc ^b   Haeffner Cavaillon, Nicole ^c  

^a CNRS   (France)

^b INSTITUT PASTEUR   (France)

^c HÔPITAL BROUSSAIS   (France)

Author keywords

Cytokines; Lipopolysaccharide heterogeneity; Receptor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; DECAY ACCELERATING FACTOR; ENDOTOXIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPID A; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; BORDETELLA; CYTOKINE PRODUCTION; DOSE RESPONSE; ENTEROBACTER; ESCHERICHIA COLI; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; REVIEW; SALMONELLA; SEPTIC SHOCK; SEROTYPE; STRUCTURE ACTIVITY RELATION;

ANIMALS; BACTERIA; CYTOKINES; HUMANS; IMMUNITY, NATURAL; LIPOPOLYSACCHARIDES; MOLECULAR STRUCTURE; MONOCYTES; SHOCK, SEPTIC; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS);

EID: 0036069961     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)01612-X     Document Type: Review

References (88)

1. Chemische Erforschung von Lipopolysacchariden Gram-negativer Bakterien
2. CD14/LPS receptor exhibits lectin-like properties
3. Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes
4. Dual effects of LPS antibodies on cellular uptake of LPS and LPS induced proinflammatory functions
5. Surfactant proteins A and D bind CD14 by different mechanisms
6. Lipopolysaccharide receptor on rabbit peritoneal macrophages. I. Binding characteristics
7. Specific binding of endotoxin to human monocytes and mouse macrophages: Serum requirement
8. Binding sites for endotoxins (lipopolysaccharides) on human monocytes
9. Do endotoxins devoid of 3-deoxy-D-manno-2-octulosonic acid exist ?
10. Meningitidis bacterium is viable without endotoxin
11. Molecular aspects of endotoxins relevant to their biological functions
12. 252Cf plasma desorption mass spectrometry
13. Structural characterization of the lipids A of three Bordetella bronchiseptica strains: Variability of fatty acid substitution
14. 252Cf Plasma desorption mass spectrometry applied to the analysis of underivatized rough-type endotoxin preparations
15. Structural variability and originality of the Bordetella endotoxins
16. 252Cf-plasma desorption mass spectrometry to structural analysis of lipids A: Examples of non-conservatism in lipid A structure
17. Novel variation of lipid A structures in strains of different Yersinia species
18. Helicobacter mustelae lipid A structure differs from that of Helicobacter pylori
19. 252Cf Plasma desorption mass spectrometry of Bordetella pertussis endotoxin after nitrous deamination
20. Specific binding of lipopolysaccharides to mouse macrophages. II. Involvement of distinct lipid A substructures
21. Constitutive expression of a complement-like protein in toll and JAK gain-of-function mutants of Drosophila
22. Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen length
23. Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to Re-chemotype lipopolysaccharide and purified lipid A
24. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression
25. Ligand specific heteromeric CD14-clustering in inflammation
26. Dissociation between the interleukin 1 - Inducing capacity and limulus reactivity of lipopolysaccharides from Gram-negative bacteria
27. The potential of various lipopolysaccharides to release IL-8 and G-CSF
28. Endotoxin-induced auto-immunity in mice. III. Comparison of different endotoxin preparations
29. Augmented immunological activities of recombinant lipopolysaccharide possessing the mannose homopolymer as the O-specific polysaccharide
30. Characterization of the induction of human interleukin-1 by endotoxins
31. Polymyxin-B inhibition of LPS-induced interleukin-1 secretion by human monocytes is dependent upon the LPS origin
32. A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity
33. Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of Gram-negative sepsis
34. Low biological activity of Helicobacter pylori lipopolysaccharide
35. Lipopolysaccharide from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines
36. Correlation between the capacity to activate macrophages in vitro and the antitumor activity in vivo of lipopolysaccharide from different bacterial species
37. Bacterial lipopolysaccharides alter human endothelial cell morphology in vitro independent of cytokine secretion
38. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
39. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes
40. Lipopolysaccharide structure influences the macrophage response via CD14-independent and CD14-dependent pathways
41. Interleukin-1 induction by lipopolysaccharides: Structural requirements of the 3-deoxy-D-manno-2-octulosonic acid (KDO)
42. R.P. Darveau, Escherichia coli and Porphyromonas gingivalis lipopolysaccharide interactions with CD14: Implications for myeloid and nonmyeloid cell activation
43. CD14 employs hydrophilic regions to "capture" lipopolysaccharides
44. A conserved structural motif for lipopolysaccharide recognition by procaryotic and eucaryotic proteins
45. Toll-like receptors: A growing family of immune receptors that are differentially expressed and regulated by different leukocytes
46. Identification of the 80-kDa LPS binding protein (LMP80) as decay-accelerating factor (DAF, CD55)
47. A CD14-independent LPS receptor cluster
48. The nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide
49. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains
50. Biological activities of fragments derived from the Bordetella pertussis endotoxin: Isolation of a nontoxic, Shwartzman-negative lipid A possessing high adjuvant properties
51. Inability of pyrogenic, purified Bordetella pertussis lipid A to induce interleukin-1 release by human monocytes
52. Characterization of immunological activity of a low toxicity antitumor lipopolysaccharide from Bordetella pertussis
53. Dissociation of cell-associated interleukine 1 and IL-1 release induced by lipopolysaccharide and lipid A
54. Genetic and physical mapping of the Lps locus: Identification of the toll-4 receptor as a candidate gene in the critical region
55. A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide
56. Salmonella-type heptaacylated lipid A is inactive and acts as an antagonist of lipopolysaccharide action on human line cells
57. Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS
58. Lipopolysaccharide of Burkholderia cepacia and its unique character to stimulate murine macrophages with relative lack of interleukine-1β-inducing ability
59. Lipopolysaccharide-induced production of tumour necrosis factor and interleukin-1 is differentially regulated at the receptor level: The role of CD14-dependent and CD14- independent pathways
60. Gram-positive and Gram-negative bacteria do not trigger monocytic cytokine production through similar intracellular pathways
61. Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: Interleukin-12 production depends on lipopolysaccharide expression in intact bacteria
62. Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response
63. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: Evidence for a soluble CD14-dependent pathway
64. CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics
65. Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)/CD16(+)/HLA-DR(+)/CD14(-/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells
66. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells
67. The role of toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2
68. Endotoxin-induced maturation of MyD88-deficient dendritic cells
69. Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation
70. Sensing pathogens and tuning immune responses
71. Characteristics of lipopolysaccharide-induced interleukin-1 production by human monocytes. Clinical relevance in patients undergoing hemodialysis
72. Lipopolysaccharide from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes
73. Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria
74. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated
75. Low endotoxic potential of Legionella pneumophila lipopolysaccharide due to failure of interaction with the monocyte lipopolysaccharide receptor CD14
76. Pathogenesis of Treponema hyodysenteria: Induction of interleukin-1 and tumor necrosis factor by a treponemal butanol/water extract (endotoxin)
77. Inability of the Francisella tularensis lipipolysaccharide to mimic or to antagonize the induction of cell activation by endotoxin
78. Comparison of cytokine induction by lipopolysaccharide of Bacteroides fragilis with Salmonella typhimurium in mice
79. Tumor necrosis factor induction by an aqueous phenol-extracted lipopolysaccharide complex from Bacteroides species
80. Functional role of interleukin 1 in periodontal disease: Induction of interleukin 1 production by Bacteroides gingivalis
81. Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages
82. Kinetics studies of the production of nitric oxide and tumor necrosis factor in macrophages stimulated with Burkholderia pseudomallei endotoxin
83. Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide, and heat-inactivated bacteria
84. Differential expression of IL-1β, TNFα, IL-6 and IL-8 in human monocytes in response to lipopolysaccharide from different microbes